MAM
India 2030 Conclave 2026 honours 56 leaders across business, cinema
NexBrands event in Mumbai spotlights icons shaping India’s next decade
MUMBAI: The ninth edition of the India 2030 Leadership Conclave 2026 wrapped up in Mumbai, bringing together a cross-section of business leaders, entertainers and cultural voices, while recognising 56 standout achievers shaping India’s future.
Organised by NexBrands Inc, the conclave was held at ITC Maratha and focused on leadership, innovation and long-term impact as India looks ahead to the next decade.
Among the headline winners were Gaur Gopal Das, named transformational thought leader of the year, Radhika Madan as breakthrough performer, and Malaika Arora, recognised as a dynamic business and entertainment icon. Film veterans Manoj Bajpayee and Nawazuddin Siddiqui were honoured for their cinematic excellence, while Shehnaaz Gill and Boman Irani were also among the prominent awardees.
From the corporate world, Ashishkumar Chauhan was recognised as the most powerful CEO in financial services, while healthcare and innovation leaders such as Mukesh Batra and Dr Murtaza Khorakiwala were also honoured.
The event was attended by chief guest Pratap Sarnaik, underlining its growing stature as a platform that bridges governance, business and culture.
A key highlight was a fireside chat featuring Mukesh Batra and Akshay Batra, who discussed how trust and legacy are becoming central to brand building in an increasingly competitive landscape.
Another moment that stood out came from Sonu Sood, who used the platform to announce his “Ab Rukna Nahi” initiative aimed at enabling free knee replacement surgeries, reinforcing the event’s blend of business dialogue and social impact.
“The India 2030 Leadership Conclave serves as a powerful platform that brings together visionary leaders and change-makers shaping the future of India,” said Kamdhenu Ltd whole time director Sunil Agarwal.
Echoing the sentiment, NexBrands Inc founder Chandrika Maheshwari said the conclave was designed to spotlight voices shaping industries and the nation’s future, while CEO Saurav Dasgupta added that conversations around trust and innovation are becoming increasingly relevant.
With participation from sectors ranging from entertainment and healthcare to manufacturing and digital innovation, the conclave also handed out a wide array of corporate honours to brands such as Tata CliQ Luxury, Reliance Retail and ICICI Prudential AMC.
Backed by partners including Kamdhenu Nxt and supported by media platforms like Times Now and IndiaTimes, the event saw strong amplification across broadcast and digital channels.
As the curtains fall on its ninth edition, the conclave continues to cement its place as a meeting ground for ideas, influence and ambition, capturing the pulse of a rapidly evolving India.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
